Google Chrome
Safari
Firefox
Edge
Press Room
Continuous Manufacturing Forum
Register now - Continuous Manufacturing Forum
The advancements of Continuous Tableting (CT) are sparking a growing interest and driving insightful discussions among academia, the pharmaceutical industry, CDMOs, and equipment providers. This September Hovione experts and esteemed professionals from Merck, GEA, Pfizer, ThermoFisher, Vertex, Graz University, and others will join The Continuous Manufacturing Forum (CMF) in Princeton NJ, to embark on a journey to explore innovative solutions, delve into promising technological breakthroughs, and gain firsthand insights into how industry experts are seamlessly integrating CT in drug product development.
In this event, we embark on a journey to explore innovative solutions, delve into promising technological breakthroughs, and gain firsthand insights into how industry leaders are seamlessly integrating continuous manufacturing in small molecule drug development. The forum will feature engaging presentations, interactive workshops, and insightful panel discussions.
Don't miss this opportunity to connect with academia, the pharmaceutical industry, CDMOs, and equipment providers, and visit Hovione's CT facilities in New Jersey accompanied by our team.
Join the conference's sessions led by our experts in Continuous Tableting
"Perspectives on the 10-Year Horizon of Continuous Manufacturing"
Chaired by our expert Sarang Oka, the session will focus on the long-term evolution of CM / Continuous Tableting, featuring perspectives from academia, industry innovators, and CDMOs.
Description: The aim of the session is to look inside a hypothetical crystal ball and discuss the long-term evolution of continuous manufacturing (tableting). This is facilitated by hearing perspectives from thought-leaders on how they see the technology evolve in the medium to long term. The perspective building exercise is meant to be holistic with inputs from academia, innovators and the CDMO space and provided by experts and practitioners with meaningful, extensive first-hand experience in the technology. The session concludes with an interactive panel discussion that is meant to inspire and challenge our thinking of the evolution of the technology.
"Effective Release: Applications of Control Methods and PAT's Future"
Anthony Tantuccio will lead a discussion into the agility of CM in Oral Solid Dose (OSD) processes, highlighting Real-Time Release testing (RTRt) as a crucial element.
Description: There has been a general expectation that applying continuous manufacturing (CM) to oral solid dose (OSD) processes increases manufacturing agility. This is achieved by enabling just-in-time manufacturing and flexible batch sizes, ultimately reducing long cycles times. However, when reducing manufacturing cycle time, batch release cycle time should not become the bottleneck, therefore, an effective and equally agile release strategy should be considered.
Real Time Release testing (RTRt) can be more appropriate for CM OSD than traditional analytical release, as the later is expected to be a bottleneck and drive the batch release cadence. Spectroscopic methods have emerged as the primary process analytic technology (PAT) tool to enable RTRt due to synergies when monitoring the process dynamics. However, building, deploying, and maintaining PAT methods can result in significant overhead and CMC complexity. This session is meant to highlight some of the successes and challenges leading industrial adopters have employed to manage the balance of PAT utility vs employment of other real time methods to support RTRt.
|
|
|
Sarang Oka Production Senior Manager |
Anthony Tantuccio Fellow of Continuous Tableting at Hovione |
Learn more about and register for the Continuous Manufacturing Forum today.
| You might be interested in: |
|---|
The Future is Continuous
Meet our experts and find out if Continuous Tableting is right for your product.
- Webinar - Register today for the most comprehensive three-part webinar series about Continuous Tableting (CT) for drug product. Hovione will be joining experts from Merck, Vertex Pharmaceuticals and GEA Group to present the "Opportunities, Challenges and Success in Implementing Continuous Tableting – From R&D to Commercial Manufacturing".
- Scientific Article - Read our latest scientific article about Continuous Tableting - “Continuous Tableting and the Road to Global Adoption
Schedule your meeting today and find out how we can support your project.
